Parkinson’s-linked protein has mixed aging effects in worms
Worms engineered to make normal or mutated versions of a human protein showed different patterns of stress resistance, metabolism and age-related damage.
Limit: The abstract gives no magnitude for the lifespan reduction
Edited by Boris Djordjevic · AgingResearch.News
In Caenorhabditis elegans worms, researchers experimentally tested normal and G2019S-mutant versions of LRRK2, a human protein linked to Parkinson’s disease. They engineered worms to make either version throughout their nerve cells, then assessed aging-related traits, gene activity and molecules involved in metabolism.
The normal protein increased growth, metabolic activity and resistance to heat and oxidative stress—damage caused by reactive molecules. It also induced mild signs of nerve cell degeneration. The mutant version worsened aging-associated traits, including reduced lifespan and greater buildup of fatty substances. It also increased the vulnerability of nerve cells that use dopamine, a chemical messenger, under stress. Molecular analyses linked the mutation to reduced availability of amino acids—the building blocks of proteins—disrupted protein maintenance and more pronounced metabolic disruption.
Why it matters
The work examines whether a protein linked to Parkinson’s disease also influences broader aging processes. The authors see it as a basis for exploring approaches that target LRRK2 in specific tissues for age-related disorders.
Caveats
These experiments used genetically engineered worms and do not establish effects in people. The abstract does not quantify the lifespan reduction.
- LRRK2
- Amino acid metabolism
- Heat shock response and chaperones
- Lipid and ceramide metabolism
- Lipofuscin
- C. elegans
The paper
Macau University of Science and Technology
Experimental Neurology, Jun 10, 2026
Comments
Be the first to comment.